≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback
info icon

This is a non-core endpoint: only basic statistics are computed.

See its core counterpart C3_SMALL_INTESTINE_EXALLC for full statistics.

Malignant neoplasm of small intestine

DOID Endpoint Browser

C3_SMALL_INTESTINE

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Cause of death: ICD-10 — C17
  • Cause of death: ICD-9 — 152
  • Cause of death: ICD-8 — 152
  • Cancer registry: Topography ICD-O-3 — C17
  • Cancer registry: Morphology ICD-O-3 — ANY
  • Cancer registry: Behaviour codes — 3

2 out of 7 registries used, show all original rules.

723

4. Check minimum number of events

None

723

5. Include endpoints

None

723

6. Filter based on genotype QC (FinnGen only)

723

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF9

Similar endpoints

↥

List of similar endpoints to Malignant neoplasm of small intestine based on the number of shared cases.

Venn diagram with an highlighted set fully inside another set Similar with more cases:

Venn diagram with a set fully inside an highlighted set Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 723 325 398
Unadjusted period prevalence (%) 0.15 0.11 0.18
Median age at first event (years) 64.18 61.98 65.98

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
676
Matched controls
6759
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
C17.9
ICD-10 Finland
Malignant neoplasm: Small intestine, unspecified
1761.0
323.0
298
*
JFB00
NOMESCO Finland
Partial resection of small intestine
266.3
320.7
307
21
D37.2
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Small intestine
1077.9
239.0
220
*
130
Kela drug reimbursment
Malignant tumour
20.0
208.3
348
340
C17.2
ICD-10 Finland
Malignant neoplasm: Ileum
+∞
175.9
161
*
8240/3-C17.9
ICD-O-3
Neuroendocrine tumor, NOS, of small intestine, NOS
+∞
149.7
138
*
H01CB03
ATC
lanreotide; parenteral
330.2
135.6
133
5
H01CB02
ATC
octreotide; parenteral
746.6
129.0
123
*
E34.0
ICD-10 Finland
Carcinoid syndrome
373.3
124.8
122
*
8240/3-C17.2
ICD-O-3
Neuroendocrine tumor, NOS, of ileum
+∞
114.9
107
*
WX302
NOMESCO Finland
Thoracal epidural anesthesy
16.1
113.7
195
166
JN4BD
NOMESCO Finland
Extensive body CT
7.8
96.6
260
501
JN3BD
NOMESCO Finland
Extensive abdominal CT
7.9
91.0
240
442
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
21.9
76.5
114
62
K56.6
ICD-10 Finland
Other and unspecified intestinal obstruction
15.3
72.3
124
98
JN7AQ
NOMESCO Finland
Somatostatin receptor SPET med low dose CT
+∞
71.1
67
*
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
9.6
69.4
152
198
C17.1
ICD-10 Finland
Malignant neoplasm: Jejunum
+∞
67.9
64
*
C17.0
ICD-10 Finland
Malignant neoplasm: Duodenum
367.0
67.8
67
*
XX7JT
NOMESCO Finland
Somatostatin isotope ablative therapy
239.2
64.4
65
*
JN5ER
NOMESCO Finland
PET-CT of receptors in whole body
121.6
62.1
66
6
C17.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of small intestine
+∞
58.2
55
*
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
3.9
57.4
345
1435
JN4AD
NOMESCO Finland
Body CT examination
6.4
57.1
168
334
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
3.7
55.0
357
1566
B01AB05
ATC
enoxaparin; parenteral
3.7
53.9
344
1482
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
9.8
52.8
112
134
8249/3-C17.9
ICD-O-3
Neuroendocrine tumor, grade 2 of small intestine, NOS
+∞
51.7
49
*
A03FA01
ATC
metoclopramide; systemic, rectal
4.0
51.3
261
918
D77
ICPC
Malignant digestive neopl other/NOS
54.7
50.8
60
12
8249/3-C17.2
ICD-O-3
Neuroendocrine tumor, grade 2 of ileum
+∞
49.6
47
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
9.9
49.5
104
122
XX9AN
NOMESCO Finland
Complementary isotope examination or additional picture
134.7
47.4
50
*
JFB30
NOMESCO Finland
Right hemicolectomy
17.4
45.1
72
46
JAH00
NOMESCO Finland
Laparotomy
11.3
44.9
87
87
UJF32
NOMESCO Finland
Coloscopy
3.4
44.2
299
1286
WD225
NOMESCO Finland
Demanding therapy of methastized malignancy with hormones
25.3
41.3
58
25
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
11.3
39.9
77
76
WX408
NOMESCO Finland
General anesthesy, balanced
3.2
39.2
281
1233
8140/3-C17.0
ICD-O-3
Adenocarcinoma, NOS, of duodenum
+∞
38.9
37
*
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
17.5
38.5
61
38
A09AA02
ATC
multienzymes (lipase, protease etc.)
14.1
35.9
62
48
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
7.1
34.6
89
142
TPH07
NOMESCO Finland
Cathetrisation of artery
4.2
34.5
148
425
JN4CD
NOMESCO Finland
Very extensive body CT
6.6
34.2
93
160
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
13.1
33.6
60
50
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
5.9
33.5
99
190
JKA20
NOMESCO Finland
Cholecystectomy
9.2
33.1
71
85
302
Kela drug reimbursment
Interferon alfa
+∞
32.6
31
*
L01BC06
ATC
capecitabine; oral
7.9
32.3
76
106
JN3AD
NOMESCO Finland
Abdominal CT examination
4.5
32.3
125
324
D13.3
ICD-10 Finland
Benign neoplasm: Other and unspecified parts of small intestine
35.3
31.3
40
12
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
5.4
31.1
99
207
T73
ICPC
Neoplasm endocrine other/unspecified
+∞
29.4
28
*
B01AB10
ATC
tinzaparin; parenteral
4.9
29.3
103
240
133
Kela drug reimbursment
Severe chronic pancreatic insufficiency
17.8
28.8
45
27
JFB20
NOMESCO Finland
Ileocaecal resection
44.6
28.0
34
8
UJF30
NOMESCO Finland
Ileoscopy through colon
4.0
27.7
123
359
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.4
27.4
152
531
JAH01
NOMESCO Finland
Laparoscopy
6.9
27.2
70
111
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
12.5
27.1
49
42
UJF92
NOMESCO Finland
Capsular endoscopy
10.7
26.7
52
52
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
5.2
26.3
86
185
C10AC01
ATC
colestyramine; oral
8.0
26.0
60
81
TPH04
NOMESCO Finland
Cathetrisation of vein
2.7
25.8
213
971
K56.5
ICD-10 Finland
Intestinal adhesions [bands] with obstruction
11.4
25.5
48
45
K56.7
ICD-10 Finland
Ileus, unspecified
14.4
24.8
42
31
JF1AB
NOMESCO Finland
Passage examination of small bowell with X-ray
11.4
24.5
46
43
JFB31
NOMESCO Finland
Laparoscopic right hemicolectomy
10.9
24.4
47
46
D64.9
ICD-10 Finland
Anaemia, unspecified
3.5
24.1
124
407
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
2.4
23.8
284
1570
Z51.5
ICD-10 Finland
Palliative care
4.2
23.7
96
256
JLC30
NOMESCO Finland
Pancreatoduodenectomy
24.7
23.7
33
14
189
Kela drug reimbursment
Imatinib
34.8
23.5
30
9
N02AA05
ATC
oxycodone; systemic
2.9
23.4
163
662
A04AA02
ATC
granisetron; systemic, transdermal
4.7
23.3
84
200
9680/3-C17.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of small intestine, NOS
+∞
23.0
22
*
8246/3-C17.9
ICD-O-3
Neuroendocrine carcinoma, NOS, of small intestine, NOS
+∞
23.0
22
*
8140/3-C17.9
ICD-O-3
Adenocarcinoma, NOS, of small intestine, NOS
+∞
23.0
22
*
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
6.3
22.7
62
107
A02BC02
ATC
pantoprazole; systemic
2.3
22.2
490
3583
JN7SN
NOMESCO Finland
Somatostatin receptor SPECT
+∞
22.0
21
*
R4190
NOMESCO Finland
Nutritional therapy
7.4
21.6
52
75
L03AB05
ATC
interferon alfa-2b; parenteral
29.1
21.1
28
10
8240/3-C17.0
ICD-O-3
Neuroendocrine tumor, NOS, of duodenum
+∞
20.9
20
*
8936/3-C17.9
ICD-O-3
Gastrointestinal stromal tumor of small intestine, NOS
+∞
20.9
20
*
D37.6
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts
13.5
20.9
36
28
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
4.0
20.8
89
249
JN7AN
NOMESCO Finland
Somatostatin receptor isotope imaging
216.3
20.7
21
*
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
7.0
20.1
50
76
L01XE01
ATC
[U] imatinib; oral
32.4
19.4
25
8
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
4.3
19.0
73
185
WX402
NOMESCO Finland
General anaesthesia
2.7
18.9
142
597
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
8.0
18.9
43
57
JFA73
NOMESCO Finland
Excision of lesion of small intestine
+∞
18.8
18
*
A04AA01
ATC
ondansetron; systemic, rectal
3.7
18.7
85
250
A79
ICPC
Malignancy NOS
9.3
18.4
38
43
JF1BD
NOMESCO Finland
Very extensive small bowel CT
14.9
18.2
30
21
WW500
NOMESCO Finland
Blood transfusion
5.1
18.0
58
122
601
Kela drug reimbursment
Severe malabsorption of nutrients, mainly fats
12.4
18.0
32
27
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.1
17.9
351
2331
L03AA02
ATC
filgrastim; parenteral
6.1
17.7
49
86
D13.2
ICD-10 Finland
Benign neoplasm: Duodenum
19.3
17.4
26
14
C77.2
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes
26.4
17.0
23
9
L01AX03
ATC
temozolomide; systemic
16.8
16.7
26
16
C49.49
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the abdomen other or unspecified tumor
174.1
16.6
17
*
C78.6
ICD-10 Finland
Secondary malignant neoplasm of retroperitoneum and peritoneum
14.7
16.4
27
19
JN3CG
NOMESCO Finland
Extensive MRI examination of abdomen with high intensity magnet
25.2
16.1
22
9
8246/3-C17.2
ICD-O-3
Neuroendocrine carcinoma, NOS, of ileum
+∞
15.7
15
*
9591/3-C17.9
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of small intestine, NOS
+∞
15.7
15
*
WZC30
NOMESCO Finland
Teaching
2.6
14.9
121
525
H02AB02
ATC
dexamethasone; systemic
2.8
14.8
103
410
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
5.2
14.7
46
94
6402
FHL
Small bowel resection
43.5
14.2
17
*
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.4
14.0
131
612
D37.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Digestive organ, unspecified
18.0
13.9
21
12
K92.2
ICD-10 Finland
Gastrointestinal haemorrhage, unspecified
5.5
13.8
41
79
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
3.0
13.7
83
302
TJD00
NOMESCO Finland
Insertion of nasogastric or naso-gastroduodenal tube
8.6
13.6
29
35
JFB01
NOMESCO Finland
Laparoscopic partial resection of small intestine
+∞
13.6
13
*
8140/3-C17.2
ICD-O-3
Adenocarcinoma, NOS, of ileum
+∞
13.6
13
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
4.1
13.4
52
133
C17
ICD-10 Finland
Malignant neoplasm of small intestine
132.3
12.5
13
*
K92.1
ICD-10 Finland
Melaena
3.4
12.4
61
192
XW000
NOMESCO Finland
Bone marrow biopsy
3.7
12.2
53
151
R50.9
ICD-10 Finland
Fever, unspecified
2.3
11.7
114
541
R10.1
ICD-10 Finland
Pain localized to upper abdomen
2.2
11.6
127
636
C82.9
ICD-10 Finland
Follicular lymphoma, unspecified
19.3
11.6
17
9
R11
ICD-10 Finland
Nausea and vomiting
3.0
11.6
70
252
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
2.5
11.6
94
406
JWA00
NOMESCO Finland
Repair of wound dehiscence in gastroenterological surgery
23.4
11.6
16
7
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
7.7
11.5
26
35
8140/3-C17.1
ICD-O-3
Adenocarcinoma, NOS, of jejunum
+∞
11.5
11
*
9680/3-C17.2
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of ileum
+∞
11.5
11
*
C26.0
ICD-10 Finland
Malignant neoplasm: Intestinal tract, part unspecified
122.0
11.5
12
*
XX9AD
NOMESCO Finland
Complementary CT
122.0
11.5
12
*
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
6.7
11.4
28
43
D70.82
ICD-10 Finland
Drug-induced neutropenia
7.5
11.3
26
36
C26.9
ICD-10 Finland
Malignant neoplasm: Ill-defined sites within the digestive system
35.7
11.3
14
*
JN4DD
NOMESCO Finland
Scout CT scan of torso
20.4
11.2
16
8
K56.0
ICD-10 Finland
Paralytic ileus
7.6
11.0
25
34
N02BE01
ATC
paracetamol; systemic, rectal
2.1
10.9
582
5065
316
Kela drug reimbursment
Imatinib
44.1
10.9
13
*
ZX120
NOMESCO Finland
Intravenous
2.5
10.9
87
372
K43.9
ICD-10 Finland
Other and unspecified ventral hernia without obstruction or gangrene
3.6
10.9
49
144
C82.1
ICD-10 Finland
Follicular lymphoma grade II
18.2
10.8
16
9
JN3DG
NOMESCO Finland
Very extensive MRI examination with high intensity magnet
21.9
10.7
15
7
WF049
NOMESCO Finland
Radiotherapy of metastasis
3.9
10.6
43
116
JJA20
NOMESCO Finland
Open biopsy of liver
111.7
10.4
11
*
9680/3-C17.0
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of duodenum
+∞
10.4
10
*
1522B
ICD-9 Finland
Malignant neoplasm of small intestine, including duodenum, Ileum[NEOPLASMA MALIGNUM ILEI,ALIA DEFINITA SEU NUD]
+∞
10.4
10
*
C78.8
ICD-10 Finland
Secondary malignant neoplasm of other and unspecified digestive organs
19.1
10.3
15
8
D50.0
ICD-10 Finland
Iron deficiency anaemia secondary to blood loss (chronic)
4.0
10.1
39
101
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
7.4
10.1
23
32
JDE00
NOMESCO Finland
Gastrojejunostomy
40.7
10.0
12
*
L03AA13
ATC
pegfilgrastim; parenteral
3.7
9.9
42
118
UJF02
NOMESCO Finland
Peroral enteroscopy
12.4
9.9
17
14
JAP00
NOMESCO Finland
Freeing of adhesions in the peritoneal cavity
8.3
9.9
21
26
M04AA01
ATC
allopurinol; systemic
2.1
9.8
117
608
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.0
9.8
146
830
JJB10
NOMESCO Finland
Atypcal resection of liver
55.8
9.7
11
*
TPX10
NOMESCO Finland
Implantation of vascular injection port
4.4
9.6
34
81
R10.0
ICD-10 Finland
Acute abdomen
4.2
9.6
35
86
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
7.3
9.6
22
31
E34.9
ICD-10 Finland
Endocrine disorder, unspecified
17.8
9.4
14
8
B03BA03
ATC
hydroxocobalamin; parenteral
2.9
9.4
58
213
8936/3-C17.1
ICD-O-3
Gastrointestinal stromal tumor of jejunum
+∞
9.4
9
*
D37.4
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Colon
5.6
9.3
26
48
K90.0
ICD-10 Finland
Coeliac disease
4.7
9.2
30
66
K63.1
ICD-10 Finland
Perforation of intestine (nontraumatic)
8.5
9.1
19
23
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
11.7
9.1
16
14
J01MA02
ATC
ciprofloxacin; systemic
1.7
9.1
275
1960
D75
ICPC
Malignant neoplasm colon/rectum
10.2
9.1
17
17
WD515
NOMESCO Finland
Demanding therapy of malignancy with enzyme inhibitors and similar treatments
37.2
9.0
11
*
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
3.3
9.0
45
145
JEA00
NOMESCO Finland
Appendectomy
3.0
9.0
52
185
JFB33
NOMESCO Finland
Other resection comprising small intestine and colon
18.9
9.0
13
7
JFB21
NOMESCO Finland
Laparoscopic ileocaecal resection
24.4
8.9
12
5
K65.0
ICD-10 Finland
Acute peritonitis
7.3
8.8
20
28
Z51.88
ICD-10 Finland
Other specified medical care
4.5
8.6
29
66
JDW98
NOMESCO Finland
Other transluminal endoscopic operation on stomach or duodenum
6.1
8.5
22
37
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
1.9
8.4
142
844
8240/3-C17.1
ICD-O-3
Neuroendocrine tumor, NOS, of jejunum
+∞
8.3
8
*
9717/3-C17.9
ICD-O-3
Intestinal T-cell lymphoma of small intestine, NOS
+∞
8.3
8
*
JN5SR
NOMESCO Finland
Very extensive PET-CT of receptors in upper body
+∞
8.3
8
*
WX600
NOMESCO Finland
Single shot through catheter
7.2
8.3
19
27
C84.59
ICD-10 Finland
Other and unspecified T-cell lymphomas
33.8
8.1
10
*
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
5.6
8.0
22
40
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
2.3
7.9
74
346
B81
ICPC
Anaemia vit B12/folate deficiency
3.3
7.9
38
120
R19.0
ICD-10 Finland
Intra-abdominal and pelvic swelling, mass and lump
4.5
7.8
26
59
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.2
7.7
75
357
ZXK00
NOMESCO Finland
Conversion from percutaneous endoscopic to open procedure
8.2
7.6
16
20
L01EA01
ATC
imatinib; oral (bcr-abl tyrosine kinase inhibitors)
25.3
7.6
10
*
K50.0
ICD-10 Finland
Crohn disease of small intestine
6.3
7.6
19
31
D12.6
ICD-10 Finland
Benign neoplasm: Colon, unspecified
2.6
7.6
55
224
WX704
NOMESCO Finland
Intubation
2.5
7.5
56
234
C26.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of digestive system
80.9
7.4
8
*
K50.9
ICD-10 Finland
Crohn disease, unspecified
6.1
7.4
19
32
C83.3
ICD-10 Finland
Diffuse large B-cell lymphoma
13.5
7.4
12
9
197
Kela drug reimbursment
Sunitinib
11.0
7.3
13
12
C17.3
ICD-10 Finland
Malignant neoplasm: Meckel diverticulum
+∞
7.3
7
*
E340, C179
ICD-10 Finland
NA
+∞
7.3
7
*
ZX112
NOMESCO Finland
Subcutaneous
4.4
7.3
25
59
Z80.0
ICD-10 Finland
Family history of malignant neoplasm of digestive organs
15.9
7.2
11
7
3AC01
NOMESCO Finland
NA
7.4
7.2
16
22
D12.2
ICD-10 Finland
Benign neoplasm: Ascending colon
3.5
7.2
32
95
A02BC03
ATC
lansoprazole; oral
1.6
7.2
200
1376
D13.9
ICD-10 Finland
Benign neoplasm: Ill-defined sites within the digestive system
30.3
7.2
9
*
5609X
ICD-9 Finland
Intestinal obstruction without mention of hernia, Unspecified intestinal obstruction
30.3
7.2
9
*
C83.39
ICD-10 Finland
Diffuse non-Hodgkin's large cell lymphoma UNS
20.3
7.1
10
5
JAL00
NOMESCO Finland
Biopsy of peritoneum
20.3
7.1
10
5
P01AB01
ATC
metronidazole; oral, rectal
1.6
7.1
241
1746
SPAT1153
SPAT
Removal of sutures
1.6
7.0
232
1663
ZX114
NOMESCO Finland
Intramuscular
5.0
7.0
21
43
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
11.1
6.8
12
11
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
2.6
6.8
50
205
K91.2
ICD-10 Finland
Postsurgical malabsorption, not elsewhere classified
40.5
6.8
8
*
JAK03
NOMESCO Finland
Laparotomy and peritoneal irrigation
40.5
6.8
8
*
JFC00
NOMESCO Finland
Entero-enterostomy
22.8
6.7
9
*
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.0
6.6
90
491
C83.9
ICD-10 Finland
Non-follicular (diffuse) lymphoma, unspecified
12.4
6.6
11
9
C18.09
ICD-10 Finland
Malignant tumor of caecum other or unspecified histology
12.4
6.6
11
9
R4110
NOMESCO Finland
Physiotherapy
1.6
6.5
183
1252
WD505
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of methastized malignancy
6.9
6.5
15
22
WX306
NOMESCO Finland
Lumbar epidural anesthesy
3.0
6.5
35
121
JJB50
NOMESCO Finland
Excision of segments V, VI, VII and VIII of liver
70.5
6.4
7
*
C18.99
ICD-10 Finland
Malignant tumor in unspecified location in the colon other or unspecified histology
14.5
6.4
10
7
JA3AT
NOMESCO Finland
Cathetrisation of abdominal cavity with ultrasound guidance
5.0
6.4
19
39
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
1.8
6.3
120
734
JN3KE
NOMESCO Finland
Abdominal ultrasound with added contrast
11.2
6.3
11
10
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.5
6.3
284
2182
176
Kela drug reimbursment
Regorafenib
18.2
6.3
9
5
XX3DW
NOMESCO Finland
Time consuming IT work
2.0
6.3
82
443
9691/3-C17.9
ICD-O-3
Follicular lymphoma, grade 2 of small intestine, NOS
+∞
6.3
6
*
C84.49
ICD-10 Finland
Peripheral T-cell lymphoma, unspecified cell type
26.9
6.2
8
*
K90.3
ICD-10 Finland
Pancreatic steatorrhoea
12.7
6.1
10
8
OAB73
NOMESCO Finland
Prevention and treatment of malnutrition
12.7
6.1
10
8
C82.01
ICD-10 Finland
Follicular nodular lymphoma, grade I
10.1
6.0
11
11
L01XE04
ATC
[U] sunitinib; oral
10.1
6.0
11
11

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(4035726)
279
568
7.37
142.47
1.7
1.4
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
290
755
5.74
110.96
4.5
4.2
ug/l
8.1
32.1
1.28
236
638
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
578
3291
4.77
68.76
16.3
6.5
umol/l
11.8
11.8
0.01
571
3120
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
212
608
4.52
68.35
3.4
2.3
g/l
0.2
0.2
0.68
202
569
(3024561) Albumin [Mass/volume] in Serum or Plasma
511
2759
3.91
63.37
11.0
4.9
g/l
34.0
35.0
3.96
505
2565
(3033658) Prothrombin time (PT) actual/Normal
356
1551
3.55
61.44
6.9
4.0
%
85.5
87.7
0.85
351
1512
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
132
280
5.54
60.81
3.6
3.6
u/ml
229.0
5154.5
0.75
121
236
(3000570) Elastase.pancreatic [Mass/mass] in Stool
97
182
6.00
50.67
1.4
1.5
ug/g
194.9
266.8
3.13
75
106
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
85
140
6.75
50.57
3.4
3.4
u/ml
126.1
390.1
0.78
79
134
(3013650) Neutrophils [#/volume] in Blood by Automated count
546
3403
3.47
47.23
19.6
9.2
e9/l
3.7
4.2
8.26
512
2974
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
517
3165
3.22
45.16
10.6
7.2
mmol/l
1.2
1.2
3.47
433
2689
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
204
747
3.41
44.24
6.1
4.1
u/l
229.8
258.8
1.50
192
702
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
483
2902
3.00
42.52
9.2
6.4
mmol/l
1.2
1.2
1.92
464
2624
(42870588) Differential panel, method unspecified - Blood
376
2008
2.82
40.91
9.8
5.6
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
219
884
3.12
39.88
2.8
2.6
%
19.7
22.2
1.77
194
747
(3018418) pH of Serum or Plasma
354
1879
2.73
38.27
7.0
4.2
ph
7.4
7.4
0.21
87
348
(3012095) Magnesium [Moles/volume] in Serum or Plasma
239
1034
2.96
38.26
7.9
3.4
mmol/l
0.8
0.8
1.83
230
967
(3044640) Blood type and Crossmatch panel - Blood
365
1969
2.72
38.18
3.6
2.6
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
189
719
3.21
37.89
4.0
2.8
umol/l
8.8
9.1
0.08
172
639
(3022948) Iron [Moles/volume] in Serum or Plasma
235
1019
2.94
37.33
2.9
2.6
umol/l
11.4
12.5
1.36
227
945
(40758558) Short blood count panel - Blood
296
1479
2.70
35.49
14.7
6.8
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
457
2850
2.64
34.23
5.6
4.2
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
287
1503
2.51
30.18
3.2
2.4
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
299
1601
2.48
29.90
2.9
2.2
mg/l
3.5
3.1
1.33
269
1350
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
623
4709
3.34
29.54
20.9
7.9
u/l
90.0
80.3
3.25
616
4392
(3006504) Eosinophils/100 leukocytes in Blood
431
2744
2.41
28.88
10.5
5.7
%
3.1
2.9
1.03
414
2547
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
333
1895
2.40
28.82
5.6
3.4
u/l
33.9
34.2
0.04
323
1800
(3022096) Basophils/100 leukocytes in Blood
423
2673
2.40
28.80
10.5
5.7
%
0.7
0.7
0.53
407
2486
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
345
1996
2.39
28.73
4.0
2.5
u/l
58.0
57.0
0.14
328
1840
(3032080) INR in Blood by Coagulation assay
428
2721
2.40
28.70
10.3
10.6
inr
1.2
1.3
0.66
140
754
(3001604) Monocytes [#/volume] in Blood
448
2907
2.42
28.66
10.4
5.5
e9/l
0.6
0.6
1.14
407
2481
(3019069) Monocytes/100 leukocytes in Blood
430
2754
2.39
28.14
10.8
6.0
%
9.5
8.9
3.89
414
2567
(3006315) Basophils [#/volume] in Blood
448
2922
2.40
28.10
10.4
5.6
e9/l
0.0
0.0
3.17
405
2504
(3002030) Lymphocytes/100 leukocytes in Blood
433
2801
2.36
27.41
10.7
5.9
%
25.9
26.7
0.92
416
2596
(3019198) Lymphocytes [#/volume] in Blood
451
2969
2.38
27.41
10.5
5.6
e9/l
1.6
1.9
5.69
410
2585
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
130
475
3.12
27.23
2.1
1.7
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
359
2149
2.33
27.20
7.7
3.6
mmol/l
2.3
2.3
1.80
335
1857
(3003458) Phosphate [Moles/volume] in Serum or Plasma
191
862
2.65
26.97
8.8
6.0
mmol/l
1.0
1.0
0.26
183
786
(3013826) Glucose [Moles/volume] in Serum or Plasma
521
3678
2.49
26.67
7.5
5.1
mmol/l
6.7
6.8
0.19
506
3469
(3013115) Eosinophils [#/volume] in Blood
454
3023
2.35
26.49
10.9
5.8
e9/l
0.2
0.2
0.70
410
2639
(3018010) Neutrophils/100 leukocytes in Blood
425
2763
2.31
26.08
10.5
5.6
%
58.5
57.9
0.51
407
2576
(3020779) Urea [Moles/volume] in Serum or Plasma
147
592
2.86
25.79
8.9
7.7
mmol/l
9.7
10.5
0.55
142
559
(3023368) Bacteria identified in Blood by Culture
321
1865
2.30
25.71
6.5
4.4
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
141
562
2.87
25.18
3.2
2.5
u/l
32.1
32.8
0.08
128
476
(40768797) Stomach Pathology biopsy report
178
819
2.56
23.85
1.6
1.2
—
—
—
0
0
(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma
29
8
37.68
23.15
2.0
2.9
pmol/l
50.7
90.3
—
23
8
(3026782) Osmolality of Urine
232
1270
2.22
20.52
3.5
3.0
mosm/kgh2o
572.8
559.0
0.44
204
1082
(40768441) Liver Pathology biopsy report
32
49
6.79
20.17
1.1
1.2
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
331
2101
2.06
19.70
4.0
3.1
ng/l
1772.2
1515.0
0.35
297
1822
(40768804) Tissue Pathology biopsy report
361
2366
2.05
19.66
2.7
2.2
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
386
2593
2.05
19.62
21.0
10.0
e9/l
0.0
0.0
0.08
341
2114
(3030467) Casts [#/volume] in Urine by Automated count
292
1773
2.09
19.58
4.1
3.3
e6/l
0.6
0.5
0.20
240
1352
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
25
30
8.60
19.36
2.8
1.8
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
282
1697
2.08
19.31
4.1
3.3
—
—
—
0
0
(3022145) Colonoscopy Study observation
148
686
2.46
19.15
1.4
1.3
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
310
1938
2.05
19.07
4.2
3.4
e6/l
37.1
113.3
1.41
255
1515
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
130
569
2.57
18.99
3.5
3.1
ng/l
127.1
212.9
3.84
120
524
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
25
31
8.32
18.86
2.7
1.7
%
17.8
16.8
0.09
11
14
(3001122) Ferritin [Mass/volume] in Serum or Plasma
362
2401
2.02
18.79
3.7
2.8
ug/l
154.1
152.8
0.03
341
2185
(3000850) Epithelial cells [#/volume] in Urine
237
1352
2.12
18.56
3.0
2.7
e6/l
4.8
4.5
0.25
206
1200
(3027945) Reticulocytes/100 erythrocytes in Blood
159
792
2.29
17.33
2.8
2.6
%
1.8
1.8
0.26
145
712
(3011412) CD3 cells [#/volume] in Blood
27
44
6.34
16.03
3.3
1.8
e9/l
1.0
0.9
0.18
20
23
(3002256) Pathology report gross observation
155
795
2.21
15.60
1.4
1.3
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
213
1242
2.01
15.24
6.2
3.1
mmol/l
2.5
2.5
0.05
202
1090
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
341
2327
1.88
15.23
4.2
3.3
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
327
2211
1.87
14.95
5.0
3.9
e6/l
420.5
127.6
0.70
261
1623
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
119
560
2.35
14.64
1.5
1.5
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
67
240
2.97
14.26
3.2
2.5
u/ml
0.3
0.4
0.80
35
131
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
180
1029
2.00
13.40
3.7
3.2
e6/l
2.6
2.1
0.34
102
579
(3017143) Hepatitis C virus Ab [Presence] in Serum
112
536
2.29
13.19
1.4
1.6
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
24
44
5.61
12.66
1.5
1.2
—
—
—
0
0
(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine
12
0
+∞
12.53
1.8
0.0
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
31
74
4.33
12.10
1.5
1.3
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
472
3707
1.79
12.08
5.7
3.2
u/l
68.5
55.0
1.87
455
3424
(3027801) Oxygen [Partial pressure] in Arterial blood
144
787
2.04
12.04
5.3
8.0
kpa
12.8
11.9
1.36
135
762
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
144
787
2.04
12.04
5.3
8.0
kpa
5.1
5.1
0.21
136
761
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
46
146
3.30
11.99
1.3
1.3
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
14
15
9.50
11.69
2.5
1.3
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
133
723
2.03
11.23
5.5
8.2
%
95.7
95.5
0.08
126
699
(3003396) Base excess in Arterial blood by calculation
142
791
1.99
11.19
5.2
8.0
mmol/l
-0.0
1.3
2.91
109
622
(40768795) Lymph node Pathology biopsy report
26
58
4.61
11.03
1.3
1.1
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
328
2365
1.71
11.03
3.2
2.3
nmol/l
70.2
78.0
5.86
312
2074
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
39
118
3.44
10.96
9.0
6.7
iu/ml
560.8
195.6
—
5
18
(3002173) Hemoglobin [Mass/volume] in Arterial blood
124
665
2.04
10.85
5.6
8.7
g/l
117.0
121.2
1.30
116
646
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
179
1098
1.84
10.48
3.6
2.9
e6/l
1.5
1.1
0.66
104
644
(3000991) Gas panel - Venous blood
108
557
2.10
10.47
7.9
9.3
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
72
317
2.41
10.20
1.3
2.0
g/l
1.6
1.6
0.01
57
280
(3023520) Reticulocytes [#/volume] in Blood
112
596
2.04
9.97
3.1
2.6
e9/l
64.7
70.4
1.03
89
473
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
52
198
2.75
9.90
1.4
1.3
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
70
309
2.40
9.86
1.5
1.3
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
490
4002
1.70
9.76
5.5
4.7
e6/l
1413.3
3220.2
—
6
77
(3021879) Hepatitis B virus core Ab [Presence] in Serum
75
343
2.32
9.75
1.3
1.4
—
—
—
0
0
(3012501) Base excess in Blood by calculation
41
138
3.09
9.73
5.7
4.7
mmol/l
4.6
2.4
2.91
31
92
(3005719) IgG [Mass/volume] in Serum or Plasma
91
456
2.14
9.48
3.9
2.8
g/l
9.3
10.9
2.93
84
415
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
32
95
3.48
9.27
1.6
1.4
u/ml
94.4
95.9
—
7
13
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
77
369
2.22
8.96
6.0
10.6
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
30
89
3.47
8.71
2.1
1.7
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
26
70
3.82
8.68
2.2
1.9
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
216
1465
1.68
8.67
1.5
1.3
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
11
13
8.58
8.48
2.3
1.4
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
269
1938
1.62
8.47
3.5
3.3
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
194
1288
1.69
8.41
1.8
1.8
nmol/l
1291.3
1189.5
0.60
152
960
(3021960) Folate [Moles/volume] in Serum or Plasma
228
1592
1.63
8.08
1.8
1.6
nmol/l
21.0
20.4
0.28
212
1344
(1616796) Gas panel - Central venous blood
37
131
2.92
8.07
4.9
3.9
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
73
358
2.16
8.02
1.9
1.7
g/l
1.3
1.3
0.01
67
325
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
33
110
3.10
7.98
3.0
1.9
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
342
2637
1.56
7.91
2.4
2.1
pmol/l
86.0
94.6
3.22
223
1371
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
32
106
3.11
7.82
1.6
1.4
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
128
776
1.79
7.59
2.0
1.9
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
45
185
2.53
7.40
3.8
3.3
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
487
4104
1.57
7.32
5.1
4.6
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
127
777
1.77
7.29
2.0
1.9
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
150
966
1.70
7.17
2.4
2.1
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
114
680
1.80
7.12
4.9
3.5
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
229
1645
1.57
7.04
4.7
2.8
umol/l
2681.2
9036.7
1.64
210
1409
(46235355) HIV 1 and 2 tests - Meaningful Use set
110
652
1.81
7.01
1.5
1.6
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
38
149
2.64
6.88
3.1
1.8
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
74
389
2.01
6.78
1.7
1.5
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
24
73
3.37
6.74
1.2
1.3
nmol/l
0.6
0.6
0.26
24
67
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
165
1106
1.64
6.73
2.3
1.9
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
104
616
1.80
6.63
2.2
2.2
ug/g
242.8
138.5
1.08
89
488
(3020630) Protein [Mass/volume] in Serum or Plasma
96
559
1.83
6.47
4.3
3.2
g/l
64.5
66.5
1.47
88
510
(3042111) Morphology [Interpretation] in Bone marrow Narrative
31
114
2.80
6.35
1.9
1.7
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
86
489
1.86
6.25
4.7
4.0
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
13
26
5.07
6.24
1.0
1.1
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
17
43
4.02
6.19
1.4
1.4
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
22
67
3.36
6.18
1.1
1.3
—
—
—
0
0
(3019060) Gas panel - Arterial blood
83
471
1.86
6.07
4.1
4.7
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
86
495
1.84
6.02
4.8
4.1
ng/l
115.1
90.0
1.50
75
432
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
15
36
4.23
5.84
2.1
1.8
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
15
36
4.23
5.84
2.1
1.8
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
17
45
3.84
5.84
1.9
1.7
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
37
156
2.45
5.81
2.9
1.7
—
—
—
0
0
(3044889) 12 lead EKG panel
496
4292
1.50
5.80
5.1
4.2
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
20
60
3.40
5.75
3.2
3.1
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
42
191
2.27
5.58
2.1
1.6
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
11
21
5.30
5.54
1.2
1.3
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
57
294
2.02
5.52
2.9
3.2
pmol/l
4.2
4.4
1.42
49
253
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
632
5798
1.72
5.49
33.3
16.2
mg/l
28.8
26.1
1.46
593
4701
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
21
68
3.15
5.38
1.2
1.3
nmol/l
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
12
26
4.68
5.27
1.0
1.0
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
12
26
4.68
5.27
1.0
1.0
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
17
50
3.46
5.05
2.2
1.9
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
77
453
1.78
5.02
6.0
6.8
mmol/l
24.3
24.5
0.16
68
427
(3002179) Metamyelocytes/100 leukocytes in Blood
77
457
1.77
4.88
4.7
4.0
%
0.7
0.5
0.48
24
119
(3002032) Base excess in Venous blood by calculation
99
632
1.66
4.82
9.0
3.9
mmol/l
1.5
2.0
0.46
77
505
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
10
20
5.06
4.79
2.1
3.6
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
524
5740
0.68
4.74
4.1
4.7
mmol/l
1.4
1.4
2.99
468
5205
(40767503) Oxygen content in Capillary blood by calculation
31
133
2.39
4.73
3.3
2.5
%
14.4
15.7
0.68
17
65
(40760892) CBC W Ordered Manual Differential panel - Blood
166
1200
1.50
4.71
6.0
4.7
—
—
—
0
0
(4281824)
19
63
3.07
4.70
1.1
1.2
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
12
29
4.19
4.64
5.9
6.2
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
15
43
3.54
4.63
2.9
3.0
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
79
480
1.73
4.62
5.2
4.2
%
0.2
0.1
0.19
31
150
(3017181) Myelocytes/100 leukocytes in Blood
83
513
1.70
4.56
5.1
4.1
%
0.8
0.9
0.04
34
165
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
24
93
2.63
4.51
1.0
1.1
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
14
39
3.64
4.50
3.8
2.3
e6/l
283.6
686.1
—
5
15
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
530
5778
0.69
4.45
4.2
4.8
mmol/l
4.3
4.5
5.08
474
5292
(3003181) Sodium [Moles/volume] in Urine
28
118
2.43
4.45
1.8
1.2
mmol/l
64.8
62.4
0.11
22
99
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
505
5552
0.70
4.44
3.9
4.2
mmol/l
1.3
1.3
0.90
445
5009
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
545
5909
0.68
4.41
4.4
5.3
mmol/l
2.5
2.7
4.00
487
5365
(3028308) Erythrocytes [#/volume] in Pleural fluid
21
77
2.78
4.38
1.2
1.4
e6/l
12117.6
24414.2
—
7
42
(3036481) Cortisol [Moles/volume] in Serum or Plasma
84
527
1.67
4.37
2.5
2.0
nmol/l
384.2
370.6
0.23
77
480
(3045788) Cell count panel - Pleural fluid
19
66
2.93
4.36
1.2
1.4
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
524
4705
1.41
4.12
44.8
19.7
%
14.4
13.8
13.29
518
4611
(3030905) Polymorphonuclear cells [#/volume] in Blood
25
104
2.45
4.10
2.4
3.1
e9/l
3.7
4.4
1.01
25
104
(3021601) Nitrite [Presence] in Urine by Test strip
342
2879
1.36
3.96
6.2
5.3
estimate
0.0
0.0
0.00
103
539
(3025159) Blasts/100 leukocytes in Blood
73
454
1.68
3.94
5.3
4.2
%
0.3
0.8
0.30
26
128
(3016650) Hepatitis A virus Ab [Presence] in Serum
23
95
2.47
3.84
1.0
1.1
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
305
2535
1.35
3.79
4.2
4.0
ng/l
46.9
55.4
0.17
225
1933
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
12
34
3.57
3.78
3.9
1.7
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
20
78
2.61
3.74
1.3
1.4
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
21
84
2.54
3.74
1.3
1.4
e6/l
12644.1
1569.1
—
9
55
(3037121) Protein [Mass/volume] in Urine
44
239
1.90
3.74
4.8
3.2
g/l
0.4
0.2
0.75
33
97
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
25
109
2.34
3.72
3.0
3.4
%
54.0
59.4
0.98
25
109
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
162
1218
1.43
3.69
4.1
4.1
ng/l
96.1
322.5
2.87
133
1003
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
23
97
2.42
3.68
1.6
1.2
u/ml
351.4
311.7
0.19
14
56
(3007164) IgA [Mass/volume] in Serum or Plasma
140
1027
1.45
3.64
1.7
1.5
g/l
2.3
2.7
1.51
101
592
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
51
295
1.78
3.57
5.2
5.2
%
1.5
1.6
0.44
45
279
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
50
290
1.78
3.47
2.0
1.9
ug/l
3.4
2.8
0.09
44
254
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
23
100
2.34
3.46
1.6
1.2
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
342
2920
1.32
3.44
4.5
3.9
estimate
0.0
0.0
0.50
102
529
(3023183) Ammonium ion [Moles/volume] in Plasma
32
161
2.03
3.39
2.8
2.9
umol/l
32.2
33.9
0.18
24
134
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
34
176
1.98
3.34
1.6
1.6
—
—
—
0
0
(3020891) Body temperature
48
279
1.77
3.32
4.7
4.4
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
104
736
1.48
3.24
1.7
1.6
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
336
2882
1.31
3.19
4.5
3.9
estimate
0.0
0.0
0.00
103
545
(3022217) INR in Platelet poor plasma by Coagulation assay
124
912
1.43
3.17
25.4
27.3
inr
1.3
1.3
0.21
15
115
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
178
1398
1.36
3.09
2.0
1.8
pmol/l
64901078.0
8501743.4
0.41
151
1141
(3047181) Lactate [Moles/volume] in Blood
38
211
1.85
3.06
5.2
6.7
mmol/l
1.4
1.3
0.27
29
184
(3035637) Corticotropin [Mass/volume] in Plasma
16
62
2.62
3.06
1.6
1.7
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
49
295
1.71
3.02
5.1
5.2
%
0.8
0.9
0.56
43
278
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
17
69
2.50
2.97
3.9
1.9
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
10
30
3.37
2.91
1.1
1.3
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
125
1632
0.72
2.89
1.7
1.6
mmol/l
1.4
1.4
0.03
103
1340
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
6
9
6.71
2.87
3.0
2.3
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
12
42
2.89
2.76
3.1
3.1
%
34.0
43.1
—
6
12
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
481
4374
1.30
2.76
4.7
3.8
pmol/l
14.5
15.0
4.02
446
3889
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
20
91
2.23
2.76
1.9
1.6
—
—
—
0
0
(3039000) Anion gap in Blood
30
161
1.90
2.70
5.7
7.0
mmol/l
10.3
11.5
1.76
25
147
(3018572) Chloride [Moles/volume] in Blood
30
161
1.90
2.70
5.7
7.0
mmol/l
103.8
105.2
1.25
25
147
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
9
24
3.78
2.68
1.6
1.9
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
21
99
2.15
2.67
2.2
1.6
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
12
43
2.82
2.65
1.0
1.0
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
9
25
3.63
2.58
2.4
1.7
ug/l
43.8
58.7
—
9
25
(44806118)
17
75
2.30
2.52
1.8
1.6
—
—
—
0
0
(44790049)
17
75
2.30
2.52
1.8
1.6
—
—
—
0
0
(44790047)
17
75
2.30
2.52
1.8
1.6
—
—
—
0
0
(44790048)
17
75
2.30
2.52
1.8
1.6
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
190
1549
1.31
2.52
4.6
3.6
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
8
21
3.84
2.47
1.0
1.6
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
24
124
1.97
2.43
3.8
2.7
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
18
83
2.20
2.42
1.8
1.8
g/l
1.2
1.0
0.13
12
64
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
52
339
1.58
2.40
2.8
2.4
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
21
104
2.05
2.38
1.9
1.6
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
151
1867
0.76
2.38
2.9
3.1
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
23
118
1.98
2.38
2.2
1.6
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
18
84
2.17
2.36
1.2
1.6
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
20
98
2.07
2.33
1.5
1.3
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
642
6131
1.42
2.33
38.5
19.1
mmol/l
139.3
139.7
3.36
636
5971
(3044007) Cell count panel - Peritoneal fluid
9
28
3.24
2.31
2.6
2.0
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
643
6145
1.42
2.30
38.5
19.2
mmol/l
3.9
4.0
7.91
637
5978
(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)
8
23
3.51
2.27
1.4
1.5
nmol/l
2.5
10.4
—
8
17
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
15
66
2.30
2.25
3.7
1.9
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
15
66
2.30
2.25
3.5
2.7
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
194
1612
1.28
2.20
4.5
4.1
estimate
0.0
0.0
0.50
90
516
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
12
48
2.53
2.19
6.2
4.1
u/ml
45.6
32.3
—
7
14
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
24
129
1.89
2.19
1.2
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
24
129
1.89
2.19
1.2
1.3
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
587
5545
1.31
2.15
33.5
14.9
ml/min/173m2
76.2
76.2
0.02
557
4579
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
7
19
3.71
2.15
1.7
2.6
—
—
—
0
0
(3035880) pH of Pleural fluid
11
43
2.58
2.10
1.2
1.3
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
479
4425
1.24
2.06
4.8
4.2
mm/h
18.3
13.4
5.61
441
4043
(3004588) Protein electrophoresis panel - Serum or Plasma
66
470
1.44
2.04
2.6
2.8
—
—
—
0
0
(3004451) EKG impression Narrative
11
44
2.52
2.02
1.2
1.3
—
—
—
0
0
(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection
8
26
3.10
2.02
2.5
2.8
—
73852.2
—
0
6
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
8
26
3.10
2.02
2.5
2.2
u/ml
1100.0
937.5
—
8
26
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
30
179
1.71
1.98
1.4
1.2
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
38
242
1.60
1.97
2.7
2.7
g/l
3.4
3.2
0.52
29
193
(3043410) Blood group antigens tested for on Red Blood Cells
7
21
3.36
1.97
1.9
1.6
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
30
180
1.70
1.95
1.4
1.2
—
—
—
0
0
(3027135) IgG subclass 1 [Mass/volume] in Serum
11
45
2.47
1.93
1.1
1.2
g/l
6.3
7.4
—
6
33
(3028192) IgG subclass 2 [Mass/volume] in Serum
11
45
2.47
1.93
1.1
1.2
g/l
2.1
2.9
—
6
33
(3024139) IgG subclass 3 [Mass/volume] in Serum
11
45
2.47
1.93
1.1
1.2
g/l
0.4
0.4
—
6
32
(3013139) Helicobacter pylori Ag [Presence] in Stool
51
349
1.50
1.93
1.2
1.3
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
10
39
2.59
1.92
1.5
1.2
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
7
22
3.20
1.88
1.0
1.0
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
30
182
1.68
1.88
1.4
1.2
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
11
234
0.46
1.82
1.6
1.4
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
26
153
1.73
1.82
11.1
2.8
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
24
138
1.76
1.81
1.6
1.2
—
—
—
0
0
(4062490)
11
47
2.36
1.78
1.1
1.2
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
39
259
1.53
1.72
2.6
2.6
g/l
4.1
3.7
0.45
28
189
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
5
13
3.86
1.71
1.0
1.0
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
14
68
2.08
1.71
2.1
1.7
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
21
355
0.58
1.70
1.7
1.7
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
39
260
1.53
1.69
2.6
2.6
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
39
260
1.53
1.69
2.6
2.6
g/l
7.5
7.5
0.01
29
197
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
0
49
0.00
1.69
0.0
1.0
—
573.2
—
0
30
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
0
49
0.00
1.69
0.0
1.0
—
285.4
—
0
29
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
0
49
0.00
1.69
0.0
1.0
—
43.4
—
0
27
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
30
188
1.62
1.68
1.5
1.6
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
642
6188
1.33
1.68
24.3
11.2
u/l
27.4
25.9
1.12
635
5948
(3001964) Herpes simplex virus Ag [Presence] in Specimen
6
19
3.18
1.66
2.2
1.2
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
8
31
2.60
1.66
1.9
2.1
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
7
25
2.82
1.65
2.6
2.5
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
59
431
1.40
1.63
1.8
1.7
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
12
56
2.16
1.62
1.2
1.3
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
5
14
3.59
1.62
1.0
1.1
—
—
—
0
0
(4010399)
30
457
0.64
1.60
1.7
1.5
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
138
1144
1.25
1.58
1.3
1.2
u/ml
1.1
1.5
0.54
34
307
(3003327) Ova and parasites identified in Stool by Light microscopy
25
153
1.66
1.55
1.3
1.7
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
57
419
1.39
1.53
5.6
4.0
mmol/l
1.2
1.9
0.56
40
316
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
5
15
3.35
1.52
6.6
1.9
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
5
15
3.35
1.52
1.0
1.0
—
—
—
0
0
(3024932) HLA-DR beta [Type]
5
15
3.35
1.52
1.4
1.1
—
—
—
0
0
(3024471) HLA-A [Type]
5
15
3.35
1.52
1.0
1.0
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
9
37
2.45
1.48
1.0
1.3
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
9
37
2.45
1.48
1.0
1.3
—
—
—
0
0
(3019225) pH of Specimen
83
651
1.31
1.47
6.1
4.7
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
624
6014
1.27
1.45
31.3
15.5
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
7
28
2.51
1.45
1.0
1.1
—
—
—
0
0
(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma
9
39
2.32
1.43
1.2
1.2
u/l
144.2
75.2
—
9
33
(3025130) Human papilloma virus identified in Specimen
9
40
2.27
1.40
2.3
1.7
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
7
29
2.43
1.39
1.0
1.0
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
35
240
1.48
1.37
2.7
2.7
g/l
10.6
10.6
0.01
30
208
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
9
41
2.21
1.37
1.6
1.5
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
9
41
2.21
1.37
1.6
1.5
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
22
135
1.65
1.37
1.2
1.2
—
—
—
0
0
(1002224) Polysomnography panel
10
196
0.50
1.36
1.2
1.1
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
252
2252
1.18
1.35
4.9
4.1
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
9
42
2.16
1.34
2.2
3.1
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
536
5106
1.19
1.28
37.3
17.4
%
37.0
39.4
7.69
384
3349
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
149
1275
1.21
1.28
2.0
1.7
mg/l
1.6
1.3
0.82
120
1002
(3016038) Potassium [Moles/volume] in Urine
9
44
2.06
1.27
2.1
1.1
mmol/l
33.4
35.7
—
9
39
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
9
44
2.06
1.27
1.0
1.1
—
—
—
0
0
(3023420) DNA double strand Ab [Units/volume] in Serum
10
49
2.06
1.22
1.4
1.3
—
38.2
—
0
5
(40768443) Skin Pathology biopsy report
38
273
1.41
1.20
1.1
1.3
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
185
2088
0.85
1.17
3.9
4.5
%
21.7
21.4
0.12
92
1065
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
10
50
2.01
1.17
1.2
1.1
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
5
20
2.51
1.15
2.6
1.3
—
—
—
0
0
(3013512) EKG study
218
1949
1.17
1.14
4.4
4.3
—
—
—
0
0
(3009343) pH of Capillary blood
57
442
1.31
1.14
5.9
3.9
ph
7.4
7.4
0.13
13
50
(3004716) Salmonella sp identified in Stool by Organism specific culture
35
251
1.41
1.13
1.5
1.3
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
8
40
2.01
1.12
2.0
1.8
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
72
887
0.79
1.10
1.3
1.3
u/ml
16.3
13.5
0.08
29
327
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
10
52
1.94
1.06
2.4
2.2
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
24
162
1.50
1.05
3.8
4.3
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
5
22
2.28
1.03
1.6
1.3
umol/l
4.8
5.4
—
5
12
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
20
298
0.66
1.03
1.4
1.3
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
24
163
1.49
1.03
2.1
1.7
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
66
813
0.79
1.02
4.1
4.8
%
32.7
32.1
0.15
47
534
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
330
3065
1.14
1.00
2.5
2.5
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
7
35
2.01
1.00
1.6
1.5
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
7
35
2.01
1.00
1.6
1.5
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
5
23
2.18
0.98
1.2
1.4
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
30
0.00
0.97
0.0
1.2
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
10
54
1.86
0.97
1.7
1.1
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
0
31
0.00
0.96
0.0
1.0
—
1.2
—
0
8
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
13
77
1.70
0.95
1.8
1.7
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
17
109
1.57
0.94
1.8
3.1
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
16
101
1.60
0.94
3.1
2.8
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
21
143
1.48
0.90
1.7
1.5
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
11
63
1.76
0.90
1.3
1.3
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
6
29
2.08
0.89
1.0
1.1
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
6
29
2.08
0.89
1.0
1.3
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
30
220
1.38
0.89
5.0
4.1
mg/l
55.7
88.5
0.49
23
178
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
30
220
1.38
0.89
5.0
4.1
mg/l
65.0
34.1
0.68
23
179
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
13
79
1.66
0.88
1.8
1.7
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
13
79
1.66
0.88
1.8
1.7
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
13
79
1.66
0.88
1.8
1.7
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
46
361
1.29
0.88
3.7
2.9
e6/l
0.4
0.3
0.08
46
352
(3017817) Protein [Mass] in Urine collected for unspecified duration
11
64
1.73
0.86
3.8
2.4
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
6
31
1.94
0.84
2.3
1.3
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
6
31
1.94
0.84
1.0
1.1
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
116
1318
0.86
0.80
4.6
4.2
kg/l
1.0
1.0
0.53
19
189
(3037556) Urate [Mass/volume] in Serum or Plasma
0
24
0.00
0.79
0.0
1.4
—
—
—
0
0
(4015189)
0
24
0.00
0.79
0.0
2.4
—
—
—
0
0
(3011648) Oxygen content in Venous blood
8
48
1.67
0.79
31.3
1.7
%
10.9
10.1
—
8
48
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
62
513
1.23
0.78
3.1
2.8
ml/min/173m2
58.1
61.5
0.28
28
210
(3015183) Erythrocyte sedimentation rate
0
26
0.00
0.78
0.0
1.3
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
88
754
1.19
0.78
1.6
1.4
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
9
53
1.71
0.75
1.1
1.0
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
9
53
1.71
0.75
2.0
1.2
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
12
75
1.61
0.75
1.8
1.3
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
7
38
1.85
0.73
1.0
1.3
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
7
38
1.85
0.73
1.0
1.3
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
5
25
2.01
0.73
3.4
3.6
—
—
—
0
0
(21494434) Karyotype in Bone marrow
11
68
1.63
0.72
1.5
1.3
—
—
—
0
0
(3011985) Renin [Units/volume] in Plasma
11
68
1.63
0.72
1.1
1.3
mu/l
85.0
46.3
0.21
11
61
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
21
151
1.40
0.72
1.1
1.2
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
39
310
1.27
0.71
1.2
1.2
iu/ml
136.6
113.9
0.18
11
123
(3011397) Hemoglobin [Presence] in Urine by Test strip
152
1373
1.14
0.69
3.9
3.8
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
41
331
1.25
0.66
5.2
4.1
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
28
1.79
0.66
1.2
1.1
—
—
—
0
0
(4027681)
5
29
1.73
0.64
1.2
1.1
—
—
—
0
0
(4211845)
5
29
1.73
0.64
3.4
3.3
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
12
79
1.53
0.63
1.9
1.7
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
11
71
1.56
0.62
4.0
3.0
—
—
—
0
0
(4306422)
11
71
1.56
0.62
1.5
1.2
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
5
30
1.67
0.61
1.0
1.0
—
—
—
0
0
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
5
30
1.67
0.61
1.0
1.0
—
7.2
—
0
8
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
21
277
0.75
0.60
1.6
1.7
—
—
—
0
0
(3003129) Base excess in Capillary blood by calculation
0
21
0.00
0.60
0.0
1.1
—
2.4
—
0
21
(3005988) Vibrio sp identified in Specimen by Organism specific culture
12
80
1.51
0.60
1.9
1.7
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
17
123
1.39
0.58
1.6
1.2
e6/l
14.8
38.0
0.41
12
97
(3044290) Cell count panel - Cerebral spinal fluid
15
106
1.42
0.58
1.5
1.2
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
10
149
0.67
0.57
2.7
1.6
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
16
116
1.39
0.54
1.9
1.6
iu/l
6.3
6.1
—
6
37
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
6
38
1.58
0.54
2.0
2.3
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
6
38
1.58
0.54
1.8
1.4
g/l
1.0
1.0
—
6
38
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
19
249
0.76
0.53
1.3
1.6
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
565
5774
0.90
0.53
5.4
5.0
mmol/l
6.2
6.1
1.67
536
5196
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
6
99
0.60
0.52
1.3
1.9
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
6
99
0.60
0.52
1.2
1.1
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
7
45
1.56
0.49
1.0
1.2
—
—
—
0
0
(3004119) Hemoglobin [Mass/volume] in Venous blood
50
429
1.18
0.48
8.8
3.3
g/l
121.6
127.0
0.91
50
423
(3020682) Albumin/Creatinine [Ratio] in Urine
196
2087
0.92
0.47
3.9
4.0
mg/mmol
20.9
8.6
1.20
129
1326
(3000492) Spirometry study
44
514
0.85
0.47
1.4
1.5
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
5
81
0.61
0.46
1.4
1.3
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
5
83
0.60
0.46
1.4
1.3
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
5
83
0.60
0.46
1.4
1.3
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
5
83
0.60
0.46
1.4
1.3
—
—
—
0
0
(4034850)
15
198
0.75
0.46
7.1
12.4
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
21
165
1.28
0.45
1.9
1.5
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
86
951
0.89
0.43
1.2
1.3
iu/ml
28.1
38.2
0.47
31
297
(3008898) HLA-B27 [Presence]
11
151
0.72
0.43
1.0
1.1
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
0
15
0.00
0.41
0.0
1.7
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
0
16
0.00
0.41
0.0
7.8
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
0
17
0.00
0.40
0.0
7.9
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
67
598
1.13
0.40
2.2
1.7
%
1.6
1.6
0.16
55
508
(3020961) Endomysium IgA Ab [Titer] in Serum
28
232
1.22
0.40
1.1
1.1
—
27.3
—
0
7
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
8
61
1.31
0.39
5.6
1.7
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
8
61
1.31
0.39
1.1
1.1
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
8
61
1.31
0.39
5.6
1.7
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
8
61
1.31
0.39
5.6
1.7
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
5
78
0.64
0.35
1.4
1.3
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
9
122
0.73
0.35
1.0
1.2
—
—
—
0
0
(3000012) Reticulocyte production index
6
43
1.40
0.35
1.2
1.7
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
10
73
1.38
0.34
1.3
1.1
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
10
73
1.38
0.34
4.8
4.1
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
29
246
1.19
0.34
3.0
2.2
ug/l
196.8
597.1
1.13
29
231
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
68
616
1.11
0.34
2.1
2.5
ug/l
4.0
6.7
2.13
60
542
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
6
86
0.70
0.33
1.2
1.8
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
6
46
1.31
0.33
2.8
2.9
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
6
46
1.31
0.33
2.5
2.6
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
30
257
1.17
0.32
2.8
3.0
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
6
47
1.28
0.32
1.3
1.1
—
—
—
0
0
(3017704) Immunofixation for Urine
6
47
1.28
0.32
2.7
1.6
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
6
47
1.28
0.32
1.3
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
6
47
1.28
0.32
1.3
1.1
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
7
52
1.35
0.31
1.0
1.1
—
—
—
0
0
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
12
153
0.78
0.31
1.2
1.2
—
2.7
—
0
6
(3023419) Bacteria identified in Sputum by Culture
7
99
0.70
0.31
1.6
2.8
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
16
129
1.25
0.30
1.8
1.5
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
76
825
0.91
0.30
14.5
7.8
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
7
56
1.25
0.29
1.0
1.1
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
35
307
1.15
0.29
4.9
2.8
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
13
103
1.27
0.28
1.1
1.5
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
10
76
1.32
0.28
1.4
1.1
u/ml
4.2
3.7
—
5
32
(4024509)
8
63
1.27
0.28
1.5
1.3
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
20
168
1.20
0.27
1.4
1.8
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
539
5308
1.06
0.27
5.5
4.7
mu/l
2.0
2.2
0.39
495
4759
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
17
141
1.21
0.26
1.6
1.2
mg/l
531.4
518.2
0.06
17
132
(3014051) Protein [Presence] in Urine by Test strip
16
132
1.22
0.26
1.9
2.3
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
35
311
1.13
0.25
1.2
1.2
u/ml
190.2
221.4
0.17
30
283
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
249
2574
0.95
0.25
4.6
5.3
ug/l
2.3
3.1
1.22
216
2291
(3007461) Platelets [#/volume] in Blood
644
6382
1.08
0.25
50.8
23.7
e9/l
242.9
242.6
0.03
638
6208
(4146454)
9
74
1.22
0.25
2.4
2.6
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
11
87
1.27
0.24
1.1
1.1
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
644
6384
1.08
0.24
50.8
23.7
e9/l
6.5
6.8
4.21
638
6184
(3026361) Erythrocytes [#/volume] in Blood
644
6384
1.08
0.24
50.8
23.7
e12/l
4.2
4.5
25.13
638
6186
(3045414) Leukocytes [Presence] in Urine
28
247
1.14
0.23
1.6
1.9
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
5
39
1.28
0.23
5.8
3.4
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
5
40
1.25
0.22
2.0
2.4
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
16
188
0.85
0.21
2.4
2.6
ug/min
69.4
79.3
—
8
111
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
0
11
0.00
0.21
0.0
1.4
—
6.8
—
0
5
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
12
98
1.23
0.21
1.1
1.1
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
0
12
0.00
0.21
0.0
5.4
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
6
48
1.25
0.20
1.2
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
6
48
1.25
0.20
1.3
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
6
48
1.25
0.20
1.3
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
6
48
1.25
0.20
1.3
1.1
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
14
0.00
0.20
0.0
1.3
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
0
14
0.00
0.20
0.0
8.4
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
9
112
0.80
0.20
1.1
2.0
pmol/l
198.4
227.7
—
9
103
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
549
5551
0.95
0.19
7.0
6.4
mmol/mol
40.2
40.6
0.40
524
5098
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
15
175
0.85
0.19
1.7
2.0
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
7
60
1.17
0.18
1.0
1.2
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
7
61
1.15
0.17
1.0
1.2
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
7
62
1.13
0.17
1.0
1.2
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
42
390
1.08
0.15
1.3
1.2
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
12
102
1.18
0.15
1.2
1.2
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
11
93
1.19
0.14
1.5
1.3
—
236.8
—
0
39
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
55
582
0.94
0.14
1.6
1.5
—
—
—
0
0
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
14
122
1.15
0.14
1.5
1.2
mmol/l
3.6
3.8
0.50
14
114
(3017732) Neutrophils [#/volume] in Blood
40
374
1.07
0.13
2.9
2.8
e9/l
3.1
4.1
2.98
28
275
(3037522) Nuclear Ab [Titer] in Serum
75
718
1.05
0.12
1.3
1.3
titre
440.0
473.3
0.10
14
161
(4094501)
17
153
1.11
0.11
1.0
1.1
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
10
86
1.17
0.11
1.6
1.5
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
44
464
0.94
0.10
2.3
2.2
nmol/l
12.7
13.0
0.07
39
407
(40761535) Cells panel - Urine sediment
58
555
1.05
0.10
3.6
3.3
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
145
1485
0.97
0.10
2.7
3.1
ug/l
0.8
0.8
0.01
103
1024
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
20
183
1.10
0.10
1.4
1.3
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
5
45
1.11
0.10
1.0
1.1
—
0.8
—
0
16
(4268621)
6
55
1.09
0.09
2.8
2.2
—
—
—
0
0
(3022621) pH of Urine by Test strip
42
400
1.05
0.08
3.9
3.0
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
6
56
1.07
0.08
1.0
1.1
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
6
57
1.05
0.08
1.0
1.2
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
74
716
1.04
0.08
1.3
1.4
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
6
58
1.03
0.08
1.0
1.1
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
10
113
0.88
0.08
1.2
1.2
—
31.2
—
0
10
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
196
1929
1.02
0.08
3.1
2.1
u/l
404.3
244.8
0.52
184
1812
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
7
67
1.05
0.08
1.0
1.1
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
58
601
0.96
0.07
1.3
1.4
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
8
75
1.07
0.07
1.1
1.0
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
10
89
1.13
0.07
1.4
1.4
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
9
105
0.86
0.06
1.3
1.5
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
16
148
1.08
0.06
2.1
1.6
—
—
—
0
0
(40768793) Breast Pathology biopsy report
14
129
1.09
0.05
1.2
1.3
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
20
188
1.07
0.05
8.8
5.3
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
18
169
1.07
0.05
2.2
2.0
mg/l
10.4
13.0
0.97
18
153
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
13
120
1.08
0.05
1.2
1.3
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
21
221
0.95
0.04
1.3
1.4
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
196
1975
0.99
0.03
3.2
3.2
mg/l
1251.2
236.0
1.05
133
1280
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
28
271
1.03
0.02
3.2
1.8
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
201
2023
0.99
0.02
3.2
3.1
mmol/l
7.1
7.5
0.52
166
1668
(40768800) Prostate Pathology biopsy report
16
168
0.95
0.02
1.3
1.2
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
21
218
0.96
0.02
1.1
1.0
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
25
242
1.03
0.02
1.0
1.0
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
32
328
0.97
0.02
1.2
1.4
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
10
106
0.94
0.01
1.8
1.5
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
11
107
1.03
0.00
3.2
2.7
—
—
—
0
0
(3022313) Gas panel - Capillary blood
33
335
0.98
0.00
7.6
4.0
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
12
117
1.03
0.00
1.3
1.4
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
12
123
0.98
0.00
1.2
1.1
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
25
249
1.00
0.00
1.8
1.7
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
5
52
0.96
0.00
1.4
1.1
—
0.9
—
0
18
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
7
79
0.88
0.00
3.0
3.9
—
—
—
0
0
(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
52.4
—
0
5
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3001729) Color of Synovial fluid
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3013762) Body weight Measured
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3016330) Potassium [Moles/time] in 24 hour Urine
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(44806071)
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3036525) Urea [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
6.6
—
—
—
0
0
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019174) dRVVT (LA screen)
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
14
140
1.00
0.00
3.4
3.9
mg/l
27.8
28.7
—
9
89
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
0
7
0.00
0.00
0.0
8.1
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(21494567) Legionella sp IgM Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3032743) Legionella sp IgG Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.0
—
2.3
—
0
8
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3030313) Adrenal Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
9
95
0.95
0.00
1.0
1.1
—
—
—
0
0
(3028717) Thiamine [Mass/volume] in Blood
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
6
62
0.97
0.00
1.2
1.2
mmol/l
7.3
7.2
—
6
39
(3041184) Isoniazid [Presence] in Urine
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: C3_SMALL_INTESTINE – Malignant neoplasm of small intestine

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).